Price (delayed)
$4.3
Market cap
$686.88M
P/E Ratio
71.67
Dividend/share
N/A
EPS
$0.06
Enterprise value
$1.22B
Ironwood Pharmaceuticals is a GI-focused healthcare company dedicated to creating medicines that make a difference for patients living with GI diseases. The company discovered, developed and are commercializing linaclotide, the
There are no recent dividends present for IRWD.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.